CDx Diagnostics, developer of the WATS3Dbiopsy, or Wide Area Transepithelial Sampling with 3D Tissue Analysis for the detection and surveillance of Barrett’s esophagus today announced the publication of new, pivotal, multicenter, crossover data in the latest issue of Gastrointestinal Endoscopy. The study found that WATS3D increased the detection of High-Grade Dysplasia and Esophageal Adenocarcinoma (HGD/EAC) by more than 400% compared to the standard Seattle protocol random forceps biopsy, even when those random biopsies are carefully performed in academic centers by some of the world’s most experienced endoscopis
http://news.sys-con.com/node/4133705
WATS3D Shown to be over 4X More Effective in Detecting High-Grade Dysplasia and Esophageal Adenocarcinoma